Three weeks ago, I attended a closed-door briefing where a Fortune 500 pharmaceutical company demonstrated how they’d used quantum computing to identify potential drug compounds in 3 hours — a process that previously took their supercomputers 18 months.

The room went silent. Not because the technology was impressive (though it was), but because...